Kg&L Capital Management,Llc Zoetis Inc. Transaction History

Kg&L Capital Management,Llc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$145.54 - $178.83 $406,202 - $499,114	2,791 New	2,791 $483,000
Q3 2023 Oct 19, 2023	SELL	$167.14 - $192.77 $25,572 - $29,493	-153 Reduced 6.98%	2,040 $354,000
Q2 2023 Jul 20, 2023	SELL	$160.94 - $186.23 $76,124 - $88,086	-473 Reduced 17.74%	2,193 $377,000
Q1 2023 Apr 19, 2023	SELL	$145.48 - $175.02 $240,769 - $289,658	-1,655 Reduced 38.3%	2,666 $443,000
Q4 2022 Jan 18, 2023	BUY	$131.14 - $157.47 $566,655 - $680,427	4,321 New	4,321 $0

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Kg&L Capital Management,Llc, based on Form 13F filings with the SEC.

Stay updated on Kg&L Capital Management,Llc with notifications on news.